Explores the challenges of inferring epidemiological parameters from clinical data, focusing on COVID-19 and the complexities of estimating infection fatality ratios.
Explores the significance of randomization in protein mass spectrometry and proteomics, highlighting its role in minimizing bias and ensuring research validity.